QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 medtronic-recalls-some-video-laryngoscopes-due-to-increased-risk-for-battery-overheat-explosion

Medtronic recalls devices over battery risks that could lead to explosions and updates usage instructions.

 fda-says-baxter-healthcare-recalls-certain-volara-system-single-patient-use-circuits-and-blue-ventilator-adapter-assemblies-identified-baxters-recall-of-certain-single-patient-use-circuits--blue-ventilator-adapter-assemblies-as-most-serious-type-baxter-healthcare-recall-due-to-disconnection-risk-that-may-prevent-proper-ventilation

- Reuters

 baxter-and-brian-stevens-mutually-agree-that-he-will-resign-from-his-role-as-senior-vice-president-chief-accounting-officer-and-controller-and-principal-accounting-officer---filing

On September 3, 2024, the Board of Directors of the Company approved the appointment of Joel Grade, the Company’s Executive Vic...

 rivian-chipotle-mexican-and-sirius-xm-are-among-top-10-large-cap-losers-last-week-aug-11-aug-17-are-the-others-in-your-portfolio

Ten large-cap stocks were the worst performers last week, with TME, MBLY, RIVN, CMG, LINE, SIRI, HSY, BAX, BR, and UTHR all see...

 baxter-seals-38b-deal-with-carlyle-for-its-kidney-care-segment

Baxter has agreed to sell its Kidney Care segment to Carlyle for $3.8 billion. Baxter will receive about $3.5 billion in cash, ...

 baxter-intends-to-use-after-tax-proceeds-from-kidney-care-transaction-to-reduce-its-debt-consistent-with-its-stated-capital-allocation-priorities

The transaction is expected to close in late 2024 or early 2025, subject to receipt of customary regulatory approvals and satis...

 following-completion-of-pending-sale-of-kidney-care-baxter-targets-operational-sales-growth-of-4-to-5-annually

For 2025, the company anticipates an adjusted operating margin of approximately 16.5% on a continuing operations basis, which r...

 goldman-sachs-maintains-neutral-on-baxter-intl-raises-price-target-to-40

Goldman Sachs analyst David Roman maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $36 to $40.

 jp-morgan-maintains-neutral-on-baxter-intl-lowers-price-target-to-42

JP Morgan analyst Robbie Marcus maintains Baxter Intl (NYSE:BAX) with a Neutral and lowers the price target from $44 to $42.

 wells-fargo-maintains-equal-weight-on-baxter-intl-lowers-price-target-to-40

Wells Fargo analyst Larry Biegelsen maintains Baxter Intl (NYSE:BAX) with a Equal-Weight and lowers the price target from $4...

 fda-says-on-aug-5-baxter-issues-voluntary-nationwide-recall-of-one-lot-of-heparin-sodium-09-sodium-chloride-injection-baxter-issues-recall-of-one-lot-of-heparin-sodium-09-sodium-chloride-injection-due-to-potential-for-elevated-endotoxin-levels

- Reuters

 baxter-lifts-annual-outlook-after-strong-q2-beat-medical-devices-sales

Baxter surpasses Q2 expectations with adjusted EPS of $0.68 and sales of $3.812 billion. Sales rose 3% reported and 4% constant...

 carlyles-4b-purchase-of-baxters-kidney-division-backed-by-ares-and-hps-financing

Ares Management and HPS Investment Partners lead a $3 billion credit facility to support Carlyle's potential acquisition of...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION